Duchenne Muscular Dystrophy Market is Anticipated to Grow With a CAGR of 31.8% for the Study Period of 2017-2030: DelveInsight

Duchenne Muscular Dystrophy Market is Anticipated to Grow With a CAGR of 31.8% for the Study Period of 2017-2030: DelveInsight

PR Newswire

LAS VEGAS, May 7, 2020

LAS VEGAS, May 7, 2020 /PRNewswire/ -- The growth of Duchenne Muscular Dystrophy (DMD) Market is anticipated to increase because of an increasing incidence of DMD patients as well as the launch of emerging drugs in the 7MM.

DelveInsight-Logo

DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Duchenne Muscular Dystrophy Market Insights, Epidemiology and Market Forecast-2030" to its portfolio.

Key Highlights from the report are:

Request for free sample pages to know more on Duchenne Muscular Dystrophy Market Forecast   

Duchenne Muscular Dystrophy is a progressive form of muscular dystrophy, which usually occurs in males, though in rare cases may affect females as well, causing progressive weakness and loss (atrophy) of skeletal and heart muscles.   

The disease epidemiology covered in the report proffers historical as well as forecasted Duchenne Muscular Dystrophy epidemiology, which is segmented as Diagnosed Prevalent Population of DMD, Age-specific Diagnosed Prevalence of DMD, Mutation-specific Diagnosed Prevalence of DMD and Diagnosed Prevalence of Associated Comorbidities in DMD in the 7MM market from 2017 to 2030. 

The report also covers Mutation-specific Diagnosed Prevalence of Duchenne Muscular Dystrophy, including several mutations such as Large Mutations, Small Mutations and Point Mutations with major proportion for deletions in Large Mutations subgroup.

Click here to know more on Duchenne Muscular Dystrophy pipeline

Duchenne Muscular Dystrophy report encloses the detailed analysis of DMD marketed drugs and mid and late-stage pipeline drugs.

The therapies that are approved for the DMD treatment are Vyondys 53 (Golodirsen), Emflaza, Exondys 51, Translarna along with many more.

Drugs covered in the report are:-

There are several key players robustly involved in developing potential products such as

And many others

Key Players covered in the DMD market report are:-

And many others

The reasons for buying this report:

Table of Contents

1

Key Insights

2

Duchenne Muscular Dystrophy Market Overview at a Glance

3

DMD Disease Background and Overview

4

Recognized Establishments

5

Duchenne Muscular Dystrophy Epidemiology and Patient Population

6

Country Wise-Epidemiology of DMD

6.1

United States

6.2

EU5 Countries

6.3

Germany

6.4

France

6.5

Italy

6.6

Spain

6.7

United Kingdom

6.8

Japan

7

Duchenne Muscular Dystrophy Treatment

8

General Guidelines on DMD

9

United States Guidelines on Duchenne Muscular Dystrophy

10

European Guidelines on Duchenne Muscular Dystrophy

11

Unmet Needs

12

DMD Marketed Drugs

13

Duchenne Muscular Dystrophy Emerging Drugs

13.1

Key Cross Competition

13.2

Casimersen: Sarepta Therapeutics

13.3

Puldysa (Idebenone): Santhera Pharmaceuticals

13.4

Givinostat: Italfarmaco

13.5

Edasalonexent: Catabasis Pharmaceuticals

13.6

Viltolarsen: Nippon Shinyaku (NS Pharma)

13.7

PF-06939926: Pfizer

13.8

Vamorolone: Santhera Pharmaceuticals/ReveraGen BioPharma

13.9

TAS-205: Taiho Pharmaceutical

13.10

Pamrevlumab (FG-3019): FibroGen

13.11

SRP-9001: Sarepta Therapeutics

13.12

Allogeneic Cardiosphere-Derived Cells (CAP-1002): Capricor

13.13

DS-5141b: Daiichi Sankyo

14

Duchenne Muscular Dystrophy 7 Major Market Analysis

15

The United States Market Outlook

16

EU-5 Countries: Market Outlook

16.1

Germany

16.2

France

16.3

Italy

16.4

Spain

16.5

United Kingdom

17

Japan: Market Outlook

18

Case Reports

19

Market Drivers

20

Market Barriers

21

SWOT Analysis for Duchenne Muscular Dystrophy

22

Appendix

23

DelveInsight Capabilities

24

Disclaimer

25

About DelveInsight

Request a Webex Demo to get a walk-through of the report: https://www.delveinsight.com/sample-request/duchenne-muscular-dystrophy-market

About DelveInsight 

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Related Reports:-

Contact us:
Shruti Thakur
info@delveinsight.com
+91-9650213330
DelveInsight

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg

 

Voltar noticias em Inglês